Pontus Siren

Pontus is an Innosight Partner who has been based in the Singapore office for 8 years. During his tenure, he has worked across the region and has helped clients such as Johnson & Johnson, the Ayala Group, Caltex, Singtel, Manila Water and SCG address the challenges of innovation and new growth. He has worked extensively on innovation growth strategies and capabilities and regularly advises senior managers on these topics.  He has worked across a range of markets, particularly in India, Singapore, Australia, China, the Philippines, UK, Turkey and Thailand. Pontus speaks and writes regularly on the topic of innovation, and he is the co-author of the Harvard Business Review article “Build an Innovation Engine in 90 Days” published in 2014 and the MIT Sloan Management Review article “The Next Wave of Business Models in Asia” published in 2016. Pontus has a keen interested in digital transformation and disruption and their impact on businesses across the world.

Prior to joining Innosight, Pontus was the CEO of a biotech company that was founded together with the Karolinska Institute in Stockholm. He has published numerous articles on cancer cachexia and sudden infant death syndrome in journals such as The British Journal of Cancer, Experimental Cell Research and Frontier in Neurology. He is also a co-author on a patent on the treatment of cancer cachexia. Before his biotech career Pontus worked for The Boston Consulting Group (BCG) in Helsinki, Stockholm, Copenhagen and Hamburg. During his five-year career at BCG, he worked across multiple industries including industrial and consumer goods, healthcare, logistics, banking, and retail.

Pontus has a MBA (honors) from the Helsinki School of Economics, MPhil (honors) from Cambridge University in International Relations, MPhil (honors) from Glasgow University in Russian and East European Studies and a BA in History from Hamilton college.